Pharma Intro Flashcards
Orphan Drugs
sodium nitrite, fomepizole, liposomal amphotericin B, miltefosine, rifabutin, succimer, somatropin, digoxin immune Fab (digoxin antibody), liothyronine (T3)
weakly acidic drugs
sod. phenobarbitone,
sod. sulfadiazine,
pot. penicillin-V
Weakly basic drugs
atropine sulfate,
ephedrine HCl,
chloroquine phosphate
ion trapping
A weak electrolyte crossing a membrane to
encounter a pH from which it is not able to escape
easily. This may contribute to gastric mucosal
cell damage caused by aspirin.
Inhibitors of P-gp
quinidine,
verapamil,
erythromycin, etc. enhance oral availability of digoxin and cyclosporine
P-gp inducers
Rifampin and phenobarbitone reduce the oral
bioavailability of these digoxin and cyclosporine
Luminal effect
Formation of insoluble complexes, e.g.
tetracyclines and iron preparations with calcium
salts and antacids, phenytoin with sucralfate.
Gut wall effects
Altering motility
(anticholinergics, tricyclic antidepressants, opioids,
metoclopramide) or causing mucosal damage
(neomycin, methotrexate, vinblastine)
Enzymatic BBB
Monoamine oxidase (MAO),
cholinesterase
do not allow catecholamines, 5-HT, acetylcholine, etc. to enter
brain in the active form.
Acidic drugs generally bind to:
Plasma albumin
Basic drugs generally binds to
Alpha1 acid glycoprotein
Drugs highly bound to albumin
Barbiturates benzodiazepines NSAIDs Valproic Acid Penicillins Phenytoin Tetracyclines Sulfonamide Tolbutamide Warfarin
Drugs highly binded to alpha1 acid glycoprotein
Beta blockers Bupivacaine Lidocaine Disopyramide Imipramine Methadone Prazosin Quinidine Verapamil